All Resources

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

Download PDF

High Priority: No; N/A
Percentage of patients age 2 years and older with allergic rhinitis who are offered intranasal corticosteroids (INS) or nonsedating oral antihistamines.

Denominator:
All patients age 2 years and older with a diagnosis of allergic rhinitis.

Denominator Exclusions:
None

Denominator Exceptions:
Patients with an allergy to oral antihistamines or intranasal corticosteroids.
Patients with prostate cancer or benign prostatic hypertrophy as these patients may be intolerant of medications.
Patients with a history of epistaxis due to intranasal steroids use.
Patient refusal.

Numerator:
Patients who are taking intranasal steroids (INS) or non-sedating oral antihistamines. A prescription for or medication
reconciliation of over the counter medications can be used to identify patients taking medications.
Measure Classifications:

  • Measure Type: Process
  • National Quality Strategy (NQS) domain: Effective Clinical Care
  • Meaningful Measure Area: Medication Management
  • Calculation: 1st Performance Rate
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No
No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.